“This is unfair competition, because Sputnik V has been tested in different countries.
For example, countries such as Argentina are studying the effectiveness of Sputnik V in detail and emphasize the very high effectiveness of our vaccine, "the senator said.
According to him, in the European Union, the United States and in a number of other countries "they earn money from illness."
“Taking into account that Sputnik V is not only effective, but also significantly lower in price compared to other vaccines.
At the same time, the health of people is sacrificed.
Many people, if given a choice, would be vaccinated with Sputnik V, believing it to be of very high quality.
But such an opportunity is not given, ”concluded Tsekov.
Earlier it was reported that MEP from the Czech Republic Kateřina Konecna asked the European Commission to comment on the situation regarding the "gradual examination" of the Sputnik V vaccine by the European Medicines Agency (EMA).
As the MEP explained, citizens of the European Union and non-EU countries, vaccinated with Sputnik V, face severe restrictions due to the inability to obtain a European covid certificate.